drugset / Trial / NCT00728546
NAT2 in Re-challenge of INH in Patients With Hepatitis
Phase 4
Unknown
100 enrolled
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan) · collab
NaSingle-groupOpen-labelTreatment
Summary
Apply the information of NAT2 genotyping into the re-challenge protocol of INH titration in patients with anti-TB medication induced hepatitis.
Timeline
- Start
- 2008-06
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoniazid | Small molecule | — | — |